City of Hope | Strategic Alliance Partners

Latest from City of Hope

Everolimus Improves Progression-Free Survival in Patients with Previously Treated Metastatic RCC

March 22, 2011

Article

A subgroup analysis of a randomized trial showed that patients with previously treated metastatic renal cell carcinoma had significant improvement in progression-free survival when they received everolimus.

ASH 2010: Brentuximab Vedotin Produces High Response Rate in Relapsed or Refractory Hodgkin Lymphoma

March 09, 2011

Article

An investigational drug known as brentuximab vedotin (SGN-35) achieved dramatic responses in a pivotal phase II study involving younger patients with relapsed or refractory Hodgkin lymphoma.